Eligible Companies for Exchange

Medely, a developer of a healthcare staffing marketplace, offers on-demand services aimed at simplifying the process of booking per diem jobs and multi-week assignments. The company's platform makes it easy for hospitals to book nursing and surgical professionals. It also provides the necessary tools for managing the contingent workforce, such as time tracking, billing, and credentials management. As a result, Medely helps hospitals avoid staff shortages while giving medical professionals the opportunity to find healthcare jobs that offer the freedom and flexibility to work when and where they prefer.

Modern Animal, a veterinary clinic operator, leverages technology to enhance pet care services. The company's clinic provides telemedicine, digital medical records, complimentary consultations, and routine health care access through annual memberships for both feline and canine owners. Modern Animal allows clients to book appointments online, communicate with their doctors, or order prescription medication.

Nalu Medical develops neuro-stimulation devices aimed at alleviating chronic pain. The company's innovative battery-free, micro-implantable pulse generators focus on neuromodulation, offering diverse therapy options for spinal cord and peripheral nerve stimulation. This technology enables patients with clinical conditions to access appropriate treatments and effectively manage chronic pain.

Neumora is a clinical-stage biotechnology company that is at the forefront of pioneering precision medicines for brain diseases, achieved through the amalgamation of data science and neuroscience. The company provides a precision neuroscience platform that effectively navigates through the complexity of brain disease heterogeneity to accurately match patient populations to targeted therapeutics. This assists doctors in providing more specific treatments for distinct groups of patients, while aiding researchers in creating more effective studies for their evaluation.

Neuralink is the creator of a brain-machine interface that can be implanted, specifically designed to aid individuals with paralysis. The company's interface is engineered not only to diagnose and treat human neurological disorders but also to potentially enhance human cognitive abilities. This innovation allows physicians to effectively address severe brain conditions in the short term.

Neuron23 develops an AI-driven drug discovery model focused on genetically defined neurological and immunological diseases. Using cutting-edge human genetics and their advanced AI-based drug discovery and biomarker platforms, Neuron23 aims to create therapeutics for severe diseases. This approach provides patients with genetic disorders access to improved medications.

NexHealth has developed a patient experience management platform that simplifies patient appointments by automating staff workflow. The platform features include real-time online booking, text and email billing, automatic reminders, recalls, two-way messaging, reviews, campaigns, and reports. This allows clinics and hospitals to manage all their appointment needs in one place, facilitating a seamless connection between doctors and patients at any time and from anywhere.

NextPoint specializes in developing medications aimed at enhancing the effectiveness of immunotherapies for cancer patients. The company is focused on creating a comprehensive and strategic pipeline of pioneering immunotherapies, leveraging a novel and validated checkpoint axis. This approach enables healthcare professionals to broaden the scope and potential of immunotherapy treatments.

Nference is a developer of artificial intelligence (AI)-powered software for the life sciences sector that is designed to transform unstructured data found in electronic medical records (EMR). The company's software employs neural networks for the real-time and automated extraction of insights from real-world patient datasets, delivering thorough biological and clinical insights into patient care. This empowers pharmaceutical, biotechnology, and healthcare enterprises to overcome challenges in drug discovery and clinical research.

Noah Medical develops medical robotic devices designed to diagnose and treat patients across various indications. The devices provided by the company are used for early diagnoses and treatments in sophisticated clinical environments. This allows hospitals to treat patients promptly, save lives, and minimize scarring.

Nomi Health has developed a healthcare payment platform aimed at reducing healthcare costs. Their platform bypasses intermediaries and establishes direct connections between employers, providers, and families, thus significantly reducing costs, confusion, and complexity associated with direct healthcare. This allows Nomi Health's clients to provide their employees and families with more affordable, high-quality care by eliminating processing intermediaries.

Noom, a psychology-focused digital health platform operator, offers intelligent nutritional and exercise coaching. Their mobile app blends artificial intelligence with workout guidance to provide behavioral modification programs. This helps users prevent and manage chronic conditions such as obesity, pre-diabetes, diabetes, and hypertension.

Notable is a company that offers a healthcare operations platform designed to enhance the interaction between physicians and patients. The platform features a voice-enabled application that utilizes artificial intelligence to automatically organize dialogues, dictations, and orders between physicians and patients. It also securely suggests suitable billing codes, thereby saving physicians' time while updating electronic health records.

Nutcracker Therapeutics has developed a biotech platform that is designed to create mRNA-based therapeutic drug products. The company's platform integrates proprietary hardware and software with advancements in mRNA biochemistry and nanoparticle delivery to produce optimized therapies on biochips. This enables medical professionals to discover, develop, and manufacture complex mRNA therapies and vaccines, which can greatly enhance human health.

Octagos Health has developed a cardiac remote monitoring software that is created to track and integrate device transmissions and real-time patient data. The software developed by Octagos Health merges implantable and wearable data onto a single platform. It then applies artificial intelligence to the data to decode intricate cardiac data, which is further connected to EMR (electronic medical record) systems. This allows healthcare professionals to handle large volumes of patient data and pinpoint urgent cases, ensuring no critical information is overlooked.

Odyssey Therapeutics is a biotechnology company that focuses on the development of immunomodulators and oncology drugs. The main goal of the company is to revolutionize the drug discovery field with its innovative product pipeline, while also speeding up the clinical development process. This allows the healthcare industry to have access to the next generation of precision immunomodulators and oncology medicines.

OM1 is the developer of an outcome management platform that is engineered to produce, compare, and anticipate treatment outcomes. The platform of this company collects, refines, enhances, and utilizes clinical data to offer AI-powered insights and predictions that can optimize clinical, financial, and administrative management. This enables healthcare institutions to examine and employ outcomes data in a clinically relevant and accurate manner.

Omada has developed a digital care platform intended to inspire and motivate individuals to meet their health goals through a sustainable lifestyle transformation. The platform focuses on engaging people in life-long health, one step at a time. It offers digital care programs for the prevention of health issues such as diabetes and hypertension, as well as self-management, while additionally providing support for those grappling with anxiety and depression. This allows patients to enhance their health and reach their health objectives.

Orbital Therapeutics, a developer of an RNA therapeutics platform, is committed to incorporating a critical mix of both established and emerging technologies and delivery methods. The company's aim is to progress a comprehensive and transformative collection of ribonucleic acid therapeutics that can be used to treat a variety of human diseases. This includes areas such as vaccines, immunomodulation, protein replacement, and regenerative medicine, thereby providing patients with contemporary treatment options.

Orca Bio is a developer of cell therapy products that are meticulously designed to replace diseased blood and immune systems with healthy ones in patients. The company excels in pioneering novel cell therapies through extensive research and development, aiming to revolutionize every aspect of bone marrow transplant. This enables a life-saving platform for numerous diseases, thereby assisting healthcare professionals in providing efficient treatment for their patients.

OrsoBio is a clinical-stage biopharmaceutical company focused on creating treatments for organ dysfunction. The firm is dedicated to developing therapies for obesity and related disorders, such as type 2 diabetes, MASH, and severe dyslipidemia. OrsoBio aims to enhance patients' energy metabolism, offering them improved health outcomes.

Ossium Health develops stem cell-based therapies aimed at enhancing human health, vitality, and longevity through bioengineering. These therapies target the cure of leukemia and other blood disorders, enhance organ transplantation outcomes, treat radiation poisoning, and facilitate tissue repair. By doing so, Ossium Health empowers healthcare professionals to significantly boost the well-being, vitality, and lifespan of individuals.

Ostro operates a patient engagement and telemedicine platform aimed at optimizing the patient journey, covering aspects from consumer interaction to provider education. Ostro's platform facilitates virtual consultations, manages shipping and logistics, ensures regulatory compliance, and integrates payment and financial services. This allows patients to access healthcare products and services through an online interface.

Overjet has developed an AI-driven dental platform aimed at enhancing patient care for dental payers and providers. The company's advanced artificial intelligence technology assists dental organizations in offering superior care to patients. This innovation enables dentists to accurately detect pathologies and confidently educate their patients, ensuring a higher quality of care.

Owkin is a developer of machine learning tools created to enhance biological and medical research. The company's tool merges genomics, biomedical images, and clinical data to uncover biomarkers and mechanisms associated with diseases and outcomes of treatments, aiming to develop models that offer maximum interpretability. This empowers researchers in universities, hospitals, and pharmaceutical companies to comprehend why patient responses to drugs vary, streamline the drug development process, and identify the most effective drug for each patient, thereby improving treatment results.

Pager is a virtual care platform designed to provide improved tools and access to advocacy-based healthcare and support services. Its platform unites clinical and service teams, tools, services, and data into a single collaborative interface. Featuring a simple and intuitive messaging system, it includes triage nurses to direct members to the most convenient and cost-effective care options. It also connects users with providers through video consultations or scheduled visits with primary care doctors and specialists. This enables the healthcare industry to interact easily with their care teams and receive proper guidance.

Papa has developed a platform for managing elderly care that is designed to foster social connections between older adults and families. This platform links older adults and families with thoroughly vetted companions who offer companionship and assistance. This enables employers to link members and their families with real individuals who can help with companion care, everyday tasks, and transportation.

Paradigm operates a health technology platform designed to support the clinical research ecosystem. The platform's purpose is to enhance the efficiency of clinical trials by connecting biopharmaceutical trial sponsors with healthcare providers and streamlining the process for patients. Paradigm aims to improve the healthcare sector by increasing trial efficiency, lowering participation barriers for healthcare providers, and accelerating the delivery of potentially life-saving treatments to patients.

Paradromics develops data-rate brain-computer interface technology aimed at enhancing data transmission rates between the human brain and machines. This technology provides high-volume, bidirectional data streaming between brains and computers, allowing patients with neurological disorders to overcome deficits in biological connectivity.

PathAI has developed an artificial intelligence-powered research platform designed to enhance the precision and efficiency of cancer diagnosis and therapy. The platform utilizes machine and deep learning methods to analyze large aggregated datasets, which allows for the identification of cancer cells individually. This, in turn, enables pathologists to diagnose cancer patients with speed and accuracy.

Pathalys Pharma develops advanced therapeutics aimed at addressing the unmet needs of managing late-stage chronic kidney diseases. The company has created upacicalcet, a novel calcimimetic designed to enhance the treatment of secondary hyperparathyroidism (SHPT) in hemodialysis patients. It works by mimicking calcium's effects on tissues through activating the calcium-sensing receptor found in various human organs. This innovation allows healthcare providers to better treat patients with end-stage critical kidney disease.

Pelago operates a behavioral therapy platform designed to empower individuals in overcoming addictions. The platform utilizes cognitive behavioral therapy to address the psychological aspects of addiction, helping users identify their triggers. Through animated videos, interactive exercises, and audio sessions, Pelago provides support to users, enabling them to tackle their addictions at their own pace. The platform offers a personalized coach, assisting users in their journey to recovery.

Pomelo Care is an online platform offering personalized, high-quality, and accessible maternity care for pregnant individuals and newborns. The company's service delivers customized, evidence-based prenatal and neonatal care through detailed care plans and engaging resources. This approach helps users address clinical, behavioral, and social needs, ultimately improving outcomes for both mothers and their babies.

Prime Medicine is a developer of groundbreaking gene-editing technology solutions aimed at treating genetic disorders. The company's unique genome-editing method, known as prime editing, has the capacity to rewrite DNA sequences. This innovative technology empowers healthcare professionals to precisely modify targeted DNA sequences, thereby correcting mutations that cause diseases.

Prompt is a developer of EMR and practice management software tailored for physical therapy practices. The company's software provides tools for scheduling and documentation, allowing users to efficiently organize appointments and enhance patient retention. It is designed to be adaptable, supporting the unique workflows and caseloads of clinics, thus enabling medical professionals to manage their operations effectively.

Quartet Health is a healthcare technology company focused on enhancing the lives of individuals with mental health conditions. Its collaborative technology platform and diverse services unite physicians, mental health providers, and insurance firms to effectively enhance patient health while reducing healthcare expenses. This approach ensures that patients receive affordable treatment options.

Quip is a provider of oral care products and online dental services, designed to promote good habits all day long. The company offers electric toothbrushes, a subscription service for brush heads and optional toothpaste on a dentist-recommended schedule, continuous oral health advice and support, and rewards for timely dental check-ups. This helps customers instill good oral habits from morning brushing to bedtime.

Rad AI is the developer of a generative artificial intelligence solution platform designed to streamline healthcare workflows, save time for providers, and reduce burnout. The company's platform enhances workflow efficiency by integrating seamlessly with existing processes, automating repetitive and time-consuming tasks, and boosting overall productivity. This enables radiologists to improve their workflows, maximizing both efficiency and accuracy while decreasing patient turnaround time.

Rakuten Medical specializes in developing precision-targeted cancer therapies intended to treat solid tumors. Their unique treatments comprise a cancer-targeting monoclonal antibody fused to a photoactivatable molecule that acquires anticancer properties when activated by light at the tumor location. This offers patients with recurrent head and neck cancer access to oncologic drugs that quickly kill cancer cells without damaging the surrounding healthy tissues.

RapidAI operates a neuroimaging platform designed to generate high-resolution images from non-contrast scans. The platform allows for the viewing, processing, and analysis of brain images, thereby enabling clinicians to make well-informed diagnostic and treatment decisions for stroke patients. This provides doctors with crucial support when treating strokes.

RapidSOS has developed an emergency tech platform aimed at connecting Internet of Things devices directly with first responders to enhance emergency response efficiency. The platform offers accurate location details and comprehensive data through software, enabling smooth integration between call operators, dispatchers, and mapping software. This allows rapid responders to access detailed, life-saving information swiftly.

ReCode Therapeutics, a developer of targeted delivery technology, is designed to cater to patients suffering from rare diseases. The company's platform leverages lipid nanoparticles to deliver genetic therapies accurately to specific organs and tissues. This could potentially address the shortcomings of existing gene therapy methods and offer new hope for patients with unmet medical needs. Thus, providing healthcare firms that handle life-limiting respiratory diseases with access to effective treatments.

RefleXion is the developer of a unique biology-guided radiotherapy intended to revolutionize cancer treatment modalities. Their innovative radiotherapy uses positron emission tomography (PET) in a distinctive manner, combining it with stereotactic radiotherapy for enhanced tumor localization and tracking during treatment delivery. This enables physicians to precisely pinpoint the location of cancer cells and effectively destroy them.

Regard is the developer of a healthcare platform aimed at enhancing hospital finances, patient safety, and physician satisfaction. The platform leverages artificial intelligence to extract relevant information from medical records, aid in diagnosing critical conditions, and produce accurate documentation. This enables physicians to save time, minimize liability, and maximize appropriate reimbursements.

Resilience (Healthtech) operates as an advanced biopharmaceutical manufacturing company aiming to revolutionize medicine production. The company provides a comprehensive array of tailored manufacturing solutions designed to meet the needs of biopharmaceuticals throughout the entire drug development lifecycle, from pre-clinical development to commercial supply. By offering clients customized and scalable processes, Resilience ensures high-quality production and regulatory compliance, along with facilities equipped to handle complex and innovative medicines.

Ring Therapeutics develops medical gene therapeutics using an innovative viral vector platform designed to broaden the scope of DNA-based treatments beyond simple gene replacement. This platform targets disease sites with precision at the cellular and tissue level, addressing areas such as genetic disorders, ophthalmology, oncology, and metabolic disorders. This allows healthcare companies to deliver treatments tailored to specific diseases, utilizing a diverse range of modalities and mechanisms.

Rivus Pharmaceuticals develops controlled metabolic accelerators aimed at enhancing cardio-metabolic health. The company focuses on improving cellular metabolism and addressing the root causes of common metabolic and cardiovascular diseases. They offer patients oral small-molecule therapeutics that target the fundamental metabolic risk factors contributing to cardiovascular mortality and morbidity.

Roman Health Ventures operates a direct-to-consumer telehealth platform designed to manage everything from diagnosis to the convenient delivery of medicine. The company's platform enables people to connect with doctors and provides comprehensive services, including those for erectile dysfunction and assistance with smoking cessation. This allows users to benefit from free medication delivery and customized treatment plans.